Corestreet Logo

Apellis Pharmaceuticals Inc (APLS) Insider Trading

Total insider buys:
  • $23,844,337.28
Total insider sells:
  • $104,494,428.96
Most recent insider trade:
  • Jan. 17, 2025
Most active insider trader:
  • Alec Machiels
Trader NameDateTitleAmountPriceTypeTotal Value
Jan. 17, 2025CAO715$29.96Sell$21,421.40
Jan. 17, 2025General Counsel2,201$29.96Sell$65,941.96
Jan. 17, 2025Insider2,145$29.96Sell$64,264.20
Jan. 17, 2025CFO1,730$29.96Sell$51,830.80
Jan. 17, 2025CEO6,007$29.96Sell$179,969.72
Jan. 13, 2025Insider264$28.70Sell$7,576.80
Jan. 13, 2025CEO6,247$28.70Sell$179,288.90
Jan. 13, 2025CAO783$28.70Sell$22,472.10
Jan. 13, 2025General Counsel4,965$28.70Sell$142,495.50
Jan. 13, 2025CFO2,170$28.70Sell$62,279.00
Jan. 6, 2025Insider2,816$33.81Sell$95,208.96
Dec. 23, 2024Insider63$33.09Sell$2,084.67
Sept. 16, 2024Director37,000$36.23Sell$1,340,510.00
June 21, 2024Director37,000$39.24Sell$1,451,880.00
May 8, 2024Insider78,907$42.35Sell$3,341,711.45
April 8, 2024Insider69,107$54.17Sell$3,743,526.19
April 1, 2024CFO4,000$58.66Sell$234,640.00
March 19, 2024Director18,681$57.18Sell$1,068,179.58
March 18, 2024Insider9,913$56.90Sell$564,049.70
March 15, 2024CAO184$56.46Sell$10,388.64
March 13, 2024Insider11,220$57.56Sell$645,823.20
March 1, 2024CFO6,000$63.22Sell$379,320.00
March 1, 2024CEO250,000$64.11Sell$16,027,500.00
Feb. 12, 2024CEO3,962$67.77Sell$268,504.74
Feb. 12, 2024General Counsel781$67.77Sell$52,928.37
Feb. 12, 2024Insider1,148$67.77Sell$77,799.96
Feb. 12, 2024CFO1,431$67.77Sell$96,978.87
Jan. 29, 2024General Counsel906$64.14Sell$58,110.84
Jan. 29, 2024CEO2,843$64.14Sell$182,350.02
Jan. 29, 2024Insider835$64.14Sell$53,556.90
Jan. 22, 2024General Counsel4,184$65.00Sell$271,960.00
Jan. 22, 2024CEO13,431$65.00Sell$873,015.00
Jan. 22, 2024Insider3,413$65.00Sell$221,845.00
Jan. 22, 2024CAO1,061$65.00Sell$68,965.00
Jan. 22, 2024CFO3,551$65.00Sell$230,815.00
Jan. 16, 2024General Counsel4,240$66.81Sell$283,274.40
Jan. 16, 2024CFO2,235$66.81Sell$149,320.35
Jan. 16, 2024CAO864$66.81Sell$57,723.84
Jan. 16, 2024CEO7,851$66.81Sell$524,525.31
Jan. 16, 2024Insider438$66.81Sell$29,262.78
Jan. 4, 2024Insider2,751$60.05Sell$165,197.55
Dec. 26, 2023Insider68$57.86Sell$3,934.48
Dec. 19, 2023General Counsel3,905$57.23Sell$223,483.15
Dec. 1, 2023Insider10,000$60.00Sell$600,000.00
Nov. 21, 2023CEO5,000$48.80Sell$244,000.00
Nov. 17, 2023Director1,250$47.74Sell$59,675.00
Nov. 8, 2023Insider12,000$47.27Sell$567,240.00
Oct. 23, 2023CAO132$46.04Sell$6,077.28
Oct. 23, 2023Insider131$46.04Sell$6,031.24
Oct. 17, 2023Director1,250$48.50Sell$60,625.00
First«1 of 5»Last

  • Insiders are both buying and selling Apellis Pharmaceuticals Inc stock.

  • The insider traders at Apellis Pharmaceuticals Inc are: Alec Machiels, Cedric Francois, Federico Grossi, Pascal Deschatelets, A. Sinclair Dunlop, David O Watson, Mark Jeffrey Delong, Timothy Eugene Sullivan, Adam J Townsend, Lukas Scheibler, James George Chopas, Jeffrey Eisele, Nicole D Perry, Morningside Venture Investment, Nur Nicholson, Karen Lewis, Caroline Baumal, Machiels Alec, Global Strategic Fund I Venbio, Deschatelets Pascal, Victoria L Brown, and Victoria L. Brown

  • The most active insider trader at Apellis Pharmaceuticals Inc is Alec Machiels with 30 trades.

  • Cedric Francois has sold the most Apellis Pharmaceuticals Inc stock with a total value of $35,227,865.41.

  • Morningside Venture Investment has bought the most Apellis Pharmaceuticals Inc stock with a total value of $31,651,764.04.

  • The most recent insider trade for Apellis Pharmaceuticals Inc was on Jan. 17, 2025.

  • The single biggest insider buy for Apellis Pharmaceuticals Inc was from Morningside Venture Investment with a total value of $10,000,000.00 on Nov. 18, 2021.

  • The single biggest insider sell for Apellis Pharmaceuticals Inc was from Cedric Francois with a total value of $16,027,500.00 on March 1, 2024.